ZD6474 is a small molecule inhibitor targeting multiple tyrosine kinases, including VEGFR-2 and EGFR) [17], which can block multiple intracellular signaling pathways involved in tumor growth, progression, and angiogenesis in several tumors [17-19]. Here, KDR is linked to neoplasm.